Citadel Advisors’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.45M | Sell |
16,800
-29,800
| -64% | -$2.67M | ﹤0.01% | 6795 |
|
|
2025
Q4 | $4.07M | Buy |
46,600
+30,600
| +191% | +$2.32M | ﹤0.01% | 4613 |
|
|
2025
Q3 | $916K | Buy |
16,000
+4,800
| +43% | +$276K | ﹤0.01% | 7720 |
|
|
2025
Q2 | $661K | Sell |
11,200
-20,200
| -64% | -$1.31M | ﹤0.01% | 7980 |
|
|
2025
Q1 | $2.3M | Sell |
31,400
-21,500
| -41% | -$1.78M | ﹤0.01% | 5277 |
|
|
2024
Q4 | $4.38M | Buy |
52,900
+45,300
| +596% | +$3.57M | ﹤0.01% | 4176 |
|
|
2024
Q3 | $544K | Sell |
7,600
-7,800
| -51% | -$551K | ﹤0.01% | 8087 |
|
|
2024
Q2 | $1.05M | Sell |
15,400
-31,200
| -67% | -$1.86M | ﹤0.01% | 6475 |
|
|
2024
Q1 | $2.5M | Buy |
46,600
+36,700
| +371% | +$1.97M | ﹤0.01% | 5088 |
|
|
2023
Q4 | $528K | Buy |
9,900
+7,225
| +270% | +$352K | ﹤0.01% | 7975 |
|
|
2023
Q3 | $133K | Buy |
2,675
+2,475
| +1,238% | +$138K | ﹤0.01% | 10530 |
|
|
2023
Q2 | $11.9K | Sell |
200
-3,600
| -95% | -$205K | ﹤0.01% | 13110 |
|
|
2023
Q1 | $215K | Sell |
3,800
-9,400
| -71% | -$603K | ﹤0.01% | 10057 |
|
|
2022
Q4 | $980K | Buy |
13,200
+6,900
| +110% | +$470K | ﹤0.01% | 6852 |
|
|
2022
Q3 | $375K | Buy |
6,300
+2,000
| +47% | +$120K | ﹤0.01% | 9089 |
|
|
2022
Q2 | $241K | Sell |
4,300
-1,000
| -19% | -$65.7K | ﹤0.01% | 10290 |
|
|
2022
Q1 | $391K | Sell |
5,300
-3,700
| -41% | -$257K | ﹤0.01% | 9963 |
|
|
2021
Q4 | $650K | Buy |
+9,000
| New | +$653K | ﹤0.01% | 9029 |
|
|
2021
Q2 | – | Sell |
-7,000
| Closed | -$432K | – | 13951 |
|
|
2021
Q1 | $432K | Buy |
7,000
+400
| +6% | +$25.3K | ﹤0.01% | 10012 |
|
|
2020
Q4 | $430K | Sell |
6,600
-30,000
| -82% | -$1.72M | ﹤0.01% | 8416 |
|
|
2020
Q3 | $1.81M | Sell |
36,600
-30,900
| -46% | -$1.59M | ﹤0.01% | 4903 |
|
|
2020
Q2 | $3.22M | Buy |
67,500
+10,800
| +19% | +$521K | ﹤0.01% | 3739 |
|
|
2020
Q1 | $2.41M | Buy |
56,700
+39,000
| +220% | +$1.93M | ﹤0.01% | 3847 |
|
|
2019
Q4 | $1.04M | Sell |
17,700
-600
| -3% | -$32.6K | ﹤0.01% | 5506 |
|
|
2019
Q3 | $935K | Buy |
18,300
+10,100
| +123% | +$481K | ﹤0.01% | 5713 |
|
|
2019
Q2 | $347K | Sell |
8,200
-1,200
| -13% | -$52.1K | ﹤0.01% | 7365 |
|
|
2019
Q1 | $464K | Sell |
9,400
-2,400
| -20% | -$109K | ﹤0.01% | 6915 |
|
|
2018
Q4 | $511K | Sell |
11,800
-4,900
| -29% | -$244K | ﹤0.01% | 6354 |
|
|
2018
Q3 | $948K | Buy |
16,700
+7,700
| +86% | +$405K | ﹤0.01% | 5655 |
|
|
2018
Q2 | $454K | Sell |
9,000
-1,900
| -17% | -$99.1K | ﹤0.01% | 6525 |
|
|
2018
Q1 | $543K | Buy |
+10,900
| New | +$512K | ﹤0.01% | 5750 |
|
|
2016
Q4 | – | Sell |
-11,500
| Closed | -$260K | – | 7471 |
|
|
2016
Q3 | $260K | Buy |
+11,500
| New | +$270K | ﹤0.01% | 5912 |
|
|
2016
Q1 | – | Sell |
-2,000
| Closed | -$56K | – | 7209 |
|
|
2015
Q4 | $56K | Buy |
2,000
+300
| +18% | +$7.53K | ﹤0.01% | 7217 |
|
|
2015
Q3 | $35K | Buy |
1,700
+200
| +13% | +$5.07K | ﹤0.01% | 7816 |
|
|
2015
Q2 | $39K | Sell |
1,500
-2,600
| -63% | -$65.8K | ﹤0.01% | 7827 |
|
|
2015
Q1 | $103K | Buy |
+4,100
| New | +$99.9K | ﹤0.01% | 6818 |
|
|
2014
Q4 | – | Sell |
-400
| Closed | -$8K | – | 8567 |
|
|
2014
Q3 | $8K | Buy |
400
+200
| +100% | +$4.12K | ﹤0.01% | 7804 |
|
|
2014
Q2 | $5K | Buy |
+200
| New | +$4.82K | ﹤0.01% | 7723 |
|
Other funds holding GMED
VCM
VPM
SC
Citadel Advisors's GMED Position: Q1 2026 in Review
Citadel Advisors reduced its Globus Medical (GMED) stake by 23% in Q1 2026, selling an estimated $51.5M and leaving 1,966,114 shares worth $169M. The position accounts for 0.03% of the portfolio, ranked #521.
Citadel Advisors first reported a position in GMED in Q3 2013 and has held it in 49 quarters since. The position peaked at $222M in Q4 2025. 603 funds tracked by Wall St. Rank hold GMED as of Q1 2026.
- Citadel Advisors held 1,966,114 shares of Globus Medical worth $169M as of Q1 2026.
- Citadel Advisors sold 573,282 Globus Medical shares in Q1 2026, an estimated $51.5M.
- Globus Medical made up 0.03% of Citadel Advisors's portfolio in Q1 2026, its #521 holding.
- Citadel Advisors first reported a position in Globus Medical in Q3 2013 and has held it in 49 quarters since.
- Citadel Advisors's Globus Medical position peaked at $222M in Q4 2025.
- 603 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.